Cher Shen Kiar is an associate at Inkef, where he plays a role in performing due diligence in healthcare investments and supporting portfolio management activity at Inkef. Prior to his, he had three years of R&D experiences driving biomedical projects for basic research and early phase drug discovery, where he had won grants and published in top-tier journals including Nature and Stem Cell Reports. Cher Shen holds an MRes from King's College London and a BSc from UCL.